from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1893/-

LFCtreatmentdescriptionclass of inhibitor

1.249

Amikacinug/mL Amikacintranslation

1.313

Cap5-10ug/mL Capreomycintranslation

2.078

Rox10-50 ug/mL Roxithromycintranslation

0.042

SM2-5 ug/mL Streptomycintranslation

1.639

Tet5-10 ug/mL Tetracyclinetranslation

-0.528

Rif0.2-5ug/mL Rifampicintranscription

0.223

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.299

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.104

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.576

CPZ10-50 ug/mL Chlorpromazinerespiration

0.075

Clofazimine10-13 ug/mL Clofaziminerespiration

0.464

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.213

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.674

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.995

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.648

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.428

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.534

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.268

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.423

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.355

KCN5-20 ug/mL Potassium cyaniderespiration

0.110

NaN30.2-2 mM Sodium aziderespiration

-0.387

Nigericin50 uM Nigericinrespiration

0.875

TRC10-150 ug/mL Triclosanrespiration

0.832

TRZ10-25 ug/mL Thioridazinerespiration

0.178

Valinomycin0.5-10 uM Valinomycinrespiration

0.174

ZnSO42 mM ZnSO4respiration

-0.798

menadione6-10 ug/mL Menadionerespiration

-0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.543

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.381

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.290

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.132

NRP_1Non-replicating persistence stage 1dosRassociated

-0.231

Amp0.2mg/mL AmpicillincellWall

-0.127

Cephalexin20-100 ug/mL CephalexincellWall

-0.570

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.596

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.610

EMB10-20 ug/mL EthambutolcellWall

-0.579

Eta12-40 ug/mL EthionamidecellWall

-0.637

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.112

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.475

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.974

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.558

BZA0.12 mg/mL BenzamidearomaticAmides

-0.608

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.969

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.283

H2O24 mM hydrogen peroxideDNAdamaging

0.382

Levo10 ug/mL LevofloxacinDNAdamaging

-1.176

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.551

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.274

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.678

UVUV-irradiationDNAdamaging

0.391

ARP41-4 ug/mL Antitubercular compound ARP4?

0.169

Antimycin12.5-50 ug/mL Antimycin A?

0.367

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.069

PA_110-50 ug/mL Antitubercular compound PA-1?

0.043

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.214

PA8240.2-2 ug/mL PA-824?

-0.900

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.602

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.704

Verapamil50 uM Verapamil?

-0.065

mercaptoethanol2 mM 2-Mercaptoethanol?

0.213

methoxatin10-20 ug/mL Methoxatin?